Politician trade (House)

Becton Dickinson (BDX): Rep. Jefferson Shreve (IN06) disclosed a sale $15K–$50K

Rep. Jefferson Shreve (IN06) disclosed a sale of Becton Dickinson in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
37 days
Disclosure lag
Traded
Mar 5, 2025
Disclosed
Apr 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 7, 2025InsiderOfficer sold ~$185K of BDX shares in the open market
  2. Jan 17, 2025InsiderOfficer sold ~$141K of BDX shares in the open market
  3. Jan 21, 2025Insider · 2 peopleInsiders: 2 sales (~$309K)
  4. Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
  5. Feb 12, 2025InsiderDirector sold ~$160K of BDX shares in the open market
  6. Mar 5, 2025 · this disclosureCongressDisclosed sale of BDX — reported range $15,001 - $50,000

What came next

  1. Mar 12, 2025InsiderOfficer sold ~$436K of BDX shares in the open market
  2. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
  3. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  4. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
  5. May 13, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  6. May 15, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  7. Jun 2, 2025InsiderOfficer sold ~$200K of BDX shares in the open market
  8. Jun 3, 2025FDAFDA device clearance: BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
  9. Jun 3, 2025FDARecall: REF: 666289 , BD FACS, 7-Color Setup Beads, 25 Runs, CE, IVD. Used in flow cytometry for fluorescence compensation.
  10. Jun 3, 2025FDARecall: REF: 123400,Bard Urologist's Tray, For the Obstructed Urethra
  11. Jun 3, 2025FDARecall: BD Heyman Follower Straight Tip for following sizes: 10Fr - REF:21110, 12Fr - REF:21112, 14Fr - REF: 21114, 20Fr - REF: 21120
  12. Jun 3, 2025FDARecall: REF: 335775 , BD FACS, 7-Color Setup Beads, 25 setups per kit, Rx Only, IVD. Used in flow cytometry for fluorescence compensation.
  13. Jun 3, 2025FDARecall: BD Heyman Follower Coude Tip for following sizes: 12Fr - REF:021312 14Fr - REF:021314, 16Fr - REF: 021316
  14. Jun 12, 2025FDAFDA device clearance: Bard® Mesh; Bard® Mesh Pre-Shaped
  15. Jun 16, 2025FDAFDA device clearance: BD Veritor System for SARS-CoV-2
  16. Jun 17, 2025FDAFDA device clearance: Dorado™ PTA Balloon Dilatation Catheter
  17. Jun 18, 2025FDAFDA device clearance: PowerPort™ isp Implantable Port; PowerPort™ Slim Implantable Port; PowerPort™ M.R.I. ™ Implantable Port; PowerPort™ M.R.I.™ isp Implantable Port
  18. Jun 18, 2025FDARecall: Bardex Lubri-Sil I.C. 400-series Temperature Sensing Silver/Hydrogel Coated All-Silicone Foley Catheter 5cc Balloon, REF: 119314; SureStep Foley Tray System Lu…
  19. Jun 20, 2025FDAFDA device clearance: BD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD Intelliport Gateway (516232); BD Intelliport Mount (516233); BD Intel…
  20. Jun 23, 2025FDARecall: BD COR System Software. Model Number: 444829.
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Rep. Jefferson Shreve (IN06)

The full history of Rep. Jefferson Shreve (IN06) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Becton Dickinson (BDX) stock, and how much?

Rep. Jefferson Shreve (IN06) disclosed a sale of Becton Dickinson in the $15K–$50K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Mar 5, 2025. Disclosed: Apr 11, 2025. That is 37 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data